Clinical Trials Directory

Trials / Conditions / Primary Hepatocellular Carcinoma

Primary Hepatocellular Carcinoma

11 registered clinical trials studyying Primary Hepatocellular Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer
NCT07337031
Eastern Hepatobiliary Surgery HospitalN/A
Not Yet Recruiting29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
NCT07100236
Junjie Xu—
Not Yet RecruitingClinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma
NCT06124001
CNBG-Virogin Biotech (Shanghai) Ltd.Phase 1 / Phase 2
UnknownH101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis
NCT05872841
Tianjin Medical University Cancer Institute and HospitalPhase 2
UnknownClinical Study of MAK Immune Cells in the Treatment of PHC
NCT05242757
Zhongnan HospitalN/A
UnknownClinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma
NCT03614546
The Third Xiangya Hospital of Central South UniversityN/A
UnknownClinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
NCT03672305
The Second Hospital of Nanjing Medical UniversityEARLY_Phase 1
UnknownTranscatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatm
NCT02956772
Hunan Provincial People's HospitalPhase 2
CompletedAutologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Thera
NCT01828762
Shanghai AbelZeta Ltd.N/A
UnknownComparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcin
NCT01563484
Li Chen—
TerminatedSafety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma
NCT00966251
CureTech LtdPhase 1 / Phase 2